SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020
- PMID: 32700672
- PMCID: PMC7376847
- DOI: 10.2807/1560-7917.ES.2020.25.28.2001285
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020
Abstract
Most cases of coronavirus disease 2019 are mild or asymptomatic. Therefore, many cases remain unrecorded. We determined seroprevalence of IgG antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 3,186 regular blood donors in three German federal states between 9 March and 3 June 2020. The IgG seroprevalence was 0.91% (95% confidence interval (CI): 0.58-1.24) overall, ranging from 0.66% (95% CI: 0.13-1.19) in Hesse to 1.22% (95% CI: 0.33-2.10) in Lower-Saxony.
Keywords: COVID-19, anti-SARS-CoV-2 IgG seroprevalence in Germany; SARS-CoV-2.
Conflict of interest statement
Figures
References
-
- Sharma R, Agarwal M, Gupta M, Somendra S, Saxena SK. Clinical characteristics and differential clinical diagnosis of novel coronavirus disease 2019 (COVID-19). In: Saxena S. (editor). Coronavirus disease 2019 (COVID-19). Medical virology: from pathogenesis to disease control. Springer, Singapore:2020; p 55–70. https://doi.org/10.1007/978-981-15-4814-7_6 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources